Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;20(4):159-68.
doi: 10.5607/en.2011.20.4.159. Epub 2011 Dec 29.

The serotonin-6 receptor as a novel therapeutic target

Hyung-Mun Yun  1 , Hyewhon Rhim
Affiliations

The serotonin-6 receptor as a novel therapeutic target

Hyung-Mun Yun et al. Exp Neurobiol. 2011 Dec.

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) is an important neurotransmitter that is found in both the central and peripheral nervous systems. 5-HT mediates its diverse physiological responses through 7 different 5-HT receptor families: 5-HT(1), 5-HT(2), 5-HT(3), 5-HT(4), 5-HT(5), 5-HT(6), and 5-HT(7) receptors. Among them, the 5-HT(6) receptor (5-HT(6)R) is the most recently cloned serotonin receptor and plays important roles in the central nervous system (CNS) and in the etiology of neurological diseases. Compared to other 5-HT receptors, the 5-HT(6)R has been considered as an attractive CNS therapeutic target because it is expressed exclusively in the CNS and has no known isoforms. This review evaluates in detail the role of the 5-HT(6)R in the physiology and pathophysiology of the CNS and the potential usefulness of 5-HT(6)R ligands in the development of therapeutic strategies for the treatment of CNS disorders. Preclinical studies provide support for the use of 5-HT(6)R ligands as promising medications to treat the cognitive dysfunction associated with Alzheimer's disease, obesity, depression, and anxiety.

Keywords: Alzheimer; Fyn; Jab1; ST1936; cognitive disorders; depression.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
5-HT6R-mediated signal transduction pathways. The activation of 5-HT6R increases DARPP-32 activities by PKA [64] and ERK1/2 activities via Fyn- and PKA-dependent pathways [32]. Fyn also leads to the surface expression of 5-HT6R via a direct interaction between Fyn and the carboxyl terminus of 5-HT6Rs [32]. In addition, a novel interaction between human HT6R (iL3 and the carboxyl terminus) and Jab1 was demonstrated by Yun et al. [68]. The expression of Jab1 mediates the modulation of the membrane expression and activity of 5-HT6Rs. 5-HT6Rs also affect the cytosol/nuclear distribution of Jab1 as well as the interaction between Jab1 and c-Jun, a target protein downstream of Jab1.
See this image and copyright information in PMC

References

    1. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–366. - PMC - PubMed
    1. Walther DJ, Peter JU, Bashammakh S, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76. - PubMed
    1. Carr GV, Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology (Berl) 2011;213:265–287. - PMC - PubMed
    1. Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem. 2011;18:245–255. - PubMed
    1. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008;11:198–209. - PubMed